Jingsheng Cai

Beijing, 100191, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Enhanced PMS activation efficiency and SMX degradation performance via Fe(II)/Fe(III) cycling with efficient CCF@MoS2@GA-Fe catalyst.

Enhanced PMS activation efficiency and SMX degradation performance via Fe(II)/Fe(III) cycling with efficient CCF@MoS2@GA-Fe catalyst.

Journal: Environmental research

Published: January 14, 2025

External validation of pathological T adjustments in the ninth edition of the pleural mesothelioma tumor-node-metastasis classification.

External validation of pathological T adjustments in the ninth edition of the pleural mesothelioma tumor-node-metastasis classification.

Journal: Frontiers in oncology

Published: January 08, 2025

Recent Advances in 3D Printing Technologies for Lithium-Sulfur Batteries.

Recent Advances in 3D Printing Technologies for Lithium-Sulfur Batteries.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: December 14, 2024

Engineered circular RNA-based DLL3-targeted CAR-T therapy for small cell lung cancer.

Engineered circular RNA-based DLL3-targeted CAR-T therapy for small cell lung cancer.

Journal: Experimental hematology & oncology

Published: December 04, 2024

Validation for revision of the stage IIIA(T1N2) in the forthcoming ninth edition of the TNM classification for lung cancer.

Validation for revision of the stage IIIA(T1N2) in the forthcoming ninth edition of the TNM classification for lung cancer.

Journal: BMC cancer

Published: July 12, 2024

Synthetic circRNA therapeutics: innovations, strategies, and future horizons.

Synthetic circRNA therapeutics: innovations, strategies, and future horizons.

Journal: MedComm

Published: May 21, 2024

Caucasian validation of downstaging from IIB to IIA in T1N1M0 patients within the 9th edition of the non-small cell lung cancer tumor-node-metastasis staging.

Caucasian validation of downstaging from IIB to IIA in T1N1M0 patients within the 9th edition of the non-small cell lung cancer tumor-node-metastasis staging.

Journal: Cancer medicine

Published: May 14, 2024

Restoring expression of tumour suppressor PTEN by engineered circular RNA-enhanced Osimertinib sensitivity in non-small cell lung cancer.

Restoring expression of tumour suppressor PTEN by engineered circular RNA-enhanced Osimertinib sensitivity in non-small cell lung cancer.

Journal: Clinical and translational medicine

Published: May 10, 2024

N1-methylpseudouridine modification level correlates with protein expression, immunogenicity, and stability of mRNA.

N1-methylpseudouridine modification level correlates with protein expression, immunogenicity, and stability of mRNA.

Journal: MedComm

Published: April 24, 2024

RNA technology and nanocarriers empowering in vivo chimeric antigen receptor therapy.

RNA technology and nanocarriers empowering in vivo chimeric antigen receptor therapy.

Journal: Immunology

Published: March 04, 2024

Efficacy of neoadjuvant chemo-immunotherapy in non-small cell lung cancer: a real-world, multicenter, retrospective study.

Efficacy of neoadjuvant chemo-immunotherapy in non-small cell lung cancer: a real-world, multicenter, retrospective study.

Journal: Translational lung cancer research

Published: January 05, 2024

The current therapeutic cancer vaccines landscape in non-small cell lung cancer.

The current therapeutic cancer vaccines landscape in non-small cell lung cancer.

Journal: International journal of cancer

Published: November 30, 2023

Showing 1-12 of 29

Last Updated: 09/26/2026